Kliogest (Norethisterone Acetate, Estradiol)

Norethisterone acetate is a synthetic progestogen that blocks the luteinizing hormone surge, while estradiol supplies estrogenic feedback that suppresses follicle‑stimulating hormone release. Together they inhibit follicular development, prevent ovulation, thicken cervical mucus, and make the endometrium unsuitable for implantation.

The dosing regimen for Kliogest is determined by the prescribing healthcare professional based on the product’s labeling and the patient’s clinical needs. The prescriber selects the appropriate tablet strength and schedule, typically following a cyclic 21‑day active tablet course with a hormone‑free interval, but exact details must be obtained from the prescribing information.

Kliogest is classified as pregnancy category X, meaning it must not be used during pregnancy because it can harm the fetus. It is also not recommended for breastfeeding women, as the hormonal components may pass into breast milk and affect the infant. Alternative contraception methods should be considered in these situations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Kliogest. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kliogest contains norethisterone acetate and estradiol, whereas many other combined pills use ethinyl estradiol as the estrogen component. The use of estradiol may offer a more physiological estrogen profile, potentially reducing certain estrogen‑related side effects, but overall efficacy and safety remain comparable when the tablet is taken correctly.

Kliogest tablets should be stored at ambient temperature, below 25 °C, in their original blister pack or container. They must be kept away from excess moisture, heat and direct sunlight to maintain potency throughout the shelf life. Do not refrigerate or freeze the tablets.

Kliogest is taken orally, usually once daily at the same time each day, following the regimen prescribed by the healthcare provider. The tablets are swallowed with water and should not be chewed or broken. Consistent daily intake is essential for maintaining contraceptive effectiveness.

The most serious risks include thromboembolic events such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction, especially in women with cardiovascular risk factors or who smoke. Other severe concerns are severe hypertension, liver disorders, and rare allergic reactions that may require immediate medical attention.

Kliogest is contraindicated in women with a history of thromboembolic disease, estrogen‑dependent tumors, uncontrolled hypertension, active liver disease, or known hypersensitivity to its ingredients. It should also be avoided by smokers over 35 years of age and by anyone who is currently pregnant or breastfeeding.